Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

Articles published in
Heart
    May 2018
  1. DOCHERTY KF, Jhund PS
    Early use of mineralocorticoid receptor antagonists in ST-elevation myocardial infarction: is it ever too early?
    Heart. 2018 May 14. pii: heartjnl-2018-313371. doi: 10.1136/heartjnl-2018-313371
    >> Share

  2. VANEZIS AP, Arnold JR, Rodrigo G, Lai FY, et al
    Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial.
    Heart. 2018 May 10. pii: heartjnl-2018-313091. doi: 10.1136/heartjnl-2018-313091
    >> Share

    April 2018
  3. BEYGUI F, Van Belle E, Ecollan P, Machecourt J, et al
    Individual participant data analysis of two trials on aldosterone blockade in myocardial infarction.
    Heart. 2018 Apr 25. pii: heartjnl-2018-312950. doi: 10.1136/heartjnl-2018-312950
    >> Share

  4. NIJJER SS
    Clinical outcomes of potent antiplatelets compared with clopidogrel in ST elevation myocardial infarction.
    Heart. 2018 Apr 17. pii: heartjnl-2018-312967. doi: 10.1136/heartjnl-2018-312967
    >> Share

  5. MUNDAL LJ, Igland J, Veierod MB, Holven KB, et al
    Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia.
    Heart. 2018 Apr 5. pii: heartjnl-2017-312706. doi: 10.1136/heartjnl-2017-312706.
    >> Share

  6. OTTO CM
    Heartbeat: Acute myocardial infarction: one test to diagnose them all?
    Heart. 2018;104:625-627.
    >> Share

    March 2018
  7. ENGSTROM T, Nepper-Christensen L, Helqvist S, Klovgaard L, et al
    Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial.
    Heart. 2018 Mar 30. pii: heartjnl-2017-312774. doi: 10.1136/heartjnl-2017-312774
    >> Share

  8. JOHNSTONE SR, Isakson BE
    'Gaps' in targeted ischaemic injury therapies in ST-elevation myocardial infarction.
    Heart. 2018 Mar 30. pii: heartjnl-2018-313084. doi: 10.1136/heartjnl-2018-313084
    >> Share

  9. SEPEHRVAND N, James SK, Stub D, Khoshnood A, et al
    Effects of supplemental oxygen therapy in patients with suspected acute myocardial infarction: a meta-analysis of randomised clinical trials.
    Heart. 2018 Mar 29. pii: heartjnl-2018-313089. doi: 10.1136/heartjnl-2018-313089
    >> Share

  10. HAKULINEN C, Pulkki-Raback L, Virtanen M, Jokela M, et al
    Social isolation and loneliness as risk factors for myocardial infarction, stroke and mortality: UK Biobank cohort study of 479 054 men and women.
    Heart. 2018 Mar 27. pii: heartjnl-2017-312663. doi: 10.1136/heartjnl-2017-312663
    >> Share

  11. EDFORS R, Sahlen A, Szummer K, Renlund H, et al
    Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function.
    Heart. 2018 Mar 24. pii: heartjnl-2017-312436. doi: 10.1136/heartjnl-2017-312436
    >> Share

  12. GRIMALDI-BENSOUDA L, Danchin N, Dallongeville J, Falissard B, et al
    Effectiveness of new antiplatelets in the prevention of recurrent myocardial infarction.
    Heart. 2018 Mar 13. pii: heartjnl-2017-312534. doi: 10.1136/heartjnl-2017-312534
    >> Share

    February 2018
  13. LAMPREA-MONTEALEGRE JA, McClelland RL, Grams M, Ouyang P, et al
    Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease.
    Heart. 2018 Feb 22. pii: heartjnl-2017-312794. doi: 10.1136/heartjnl-2017-312794
    >> Share

  14. ELIAS J, van Dongen IM, Ramunddal T, Laanmets P, et al
    Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction.
    Heart. 2018 Feb 20. pii: heartjnl-2017-312698. doi: 10.1136/heartjnl-2017-312698
    >> Share

  15. GARD A, Lindahl B, Batra G, Hadziosmanovic N, et al
    Interphysician agreement on subclassification of myocardial infarction.
    Heart. 2018 Feb 16. pii: heartjnl-2017-312409. doi: 10.1136/heartjnl-2017-312409
    >> Share

  16. BRAVO CA, Hirji SA, Bhatt DL, Gluud C, et al
    Cochrane corner: complete versus culprit-only revascularisation in ST segment elevation myocardial infarction with multivessel disease.
    Heart. 2018 Feb 8. pii: heartjnl-2017-312857. doi: 10.1136/heartjnl-2017-312857.
    >> Share

  17. FOO CY, Bonsu KO, Nallamothu BK, Reid CM, et al
    Coronary intervention door-to-balloon time and outcomes in ST-elevation myocardial infarction: a meta-analysis.
    Heart. 2018 Feb 5. pii: heartjnl-2017-312517. doi: 10.1136/heartjnl-2017-312517.
    >> Share

    January 2018
  18. SINGH D, Bhat R, Kothari SS
    25-year-old man with chest pain.
    Heart. 2018;104:72.
    >> Share

  19. MURPHY A, Johnson CO, Roth GA, Forouzanfar MH, et al
    Ischaemic heart disease in the former Soviet Union 1990-2015 according to the Global Burden of Disease 2015 Study.
    Heart. 2018;104:58-66.
    >> Share

  20. GREY C, Jackson R, Wells S, Wu B, et al
    First and recurrent ischaemic heart disease events continue to decline in New Zealand, 2005-2015.
    Heart. 2018;104:51-57.
    >> Share

    December 2017
  21. STEWART RAH, Colquhoun DM, Marschner SL, Kirby AC, et al
    Persistent psychological distress and mortality in patients with stable coronary artery disease.
    Heart. 2017;103:1860-1866.
    >> Share

  22. ROUX V, Salaun E, Tribouilloy C, Hubert S, et al
    Coronary events complicating infective endocarditis.
    Heart. 2017;103:1906-1910.
    >> Share

  23. GNANENTHIRAN SR, Kritharides L, D'Souza M, Lowe HC, et al
    Revascularisation compared with initial medical therapy for non-ST-elevation acute coronary syndromes in the elderly: a meta-analysis.
    Heart. 2017;103:1962-1969.
    >> Share

  24. DE CARLO M, Liga R
    Elderly patients with non-ST-elevation acute coronary syndromes: a call for action.
    Heart. 2017;103:1932-1933.
    >> Share

  25. SAINSBURY PA, Fisher M, de Silva R
    Alternative interventions for refractory angina.
    Heart. 2017;103:1911-1922.
    >> Share

    November 2017
  26. DURKO AP, Budde RPJ, Geleijnse ML, Kappetein AP, et al
    Recognition, assessment and management of the mechanical complications of acute myocardial infarction.
    Heart. 2017 Nov 16. pii: heartjnl-2017-311473. doi: 10.1136/heartjnl-2017-311473
    >> Share

  27. MANGION K, Gao H, Husmeier D, Luo X, et al
    Advances in computational modelling for personalised medicine after myocardial infarction.
    Heart. 2017 Nov 10. pii: heartjnl-2017-311449. doi: 10.1136/heartjnl-2017-311449
    >> Share

  28. BAI L, Li Q, Wang J, Lavigne E, et al
    Increased coronary heart disease and stroke hospitalisations from ambient temperatures in Ontario.
    Heart. 2017 Nov 3. pii: heartjnl-2017-311821. doi: 10.1136/heartjnl-2017-311821.
    >> Share

  29. MATULEVICIENE-ANANGEN V, Rosengren A, Svensson AM, Pivodic A, et al
    Glycaemic control and excess risk of major coronary events in persons with type 1 diabetes.
    Heart. 2017;103:1687-1695.
    >> Share

  30. HOORWEG BB, Willemsen RT, Cleef LE, Boogaerts T, et al
    Frequency of chest pain in primary care, diagnostic tests performed and final diagnoses.
    Heart. 2017;103:1727-1732.
    >> Share

  31. GRAY AM, Murphy J, Altman DG, Benedetto U, et al
    One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial.
    Heart. 2017;103:1719-1726.
    >> Share

  32. SILVAIN J, Nguyen LS, Spagnoli V, Kerneis M, et al
    Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Heart. 2017 Nov 1. pii: heartjnl-2017-311975. doi: 10.1136/heartjnl-2017-311975.
    >> Share

  33. DENBY KJ, Clark DE, Markham LW
    Management of Kawasaki disease in adults.
    Heart. 2017;103:1760-1769.
    >> Share

  34. HERRINGTON WG, Bragg F
    Extreme ischaemic heart disease risk in people with type 1 diabetes.
    Heart. 2017;103:1656-1657.
    >> Share

  35. RAHIMI K, Otto CM
    Heartbeat: Glycaemic control and excess risk of major coronary events in type 1 diabetes.
    Heart. 2017;103:1653-1655.
    >> Share

    October 2017
  36. DE MARIA GL, Patel N, Banning AP
    Obstructive left main stem coronary disease: is it time to recommend coronary stenting?
    Heart. 2017 Oct 23. pii: heartjnl-2016-310880. doi: 10.1136/heartjnl-2016-310880
    >> Share

  37. OTTO CM
    Heartbeat: Virtual histopathology after myocardial infarction.
    Heart. 2017;103:1473-1474.
    >> Share

  38. OTTO CM
    Heartbeat: Ischemic heart disease risk factors in women.
    Heart. 2017;103:1559-1561.
    >> Share

  39. ASHER E, Kogan A, Segev A
    Severe upper abdominal pain in a 43-year-old woman.
    Heart. 2017;103:1650.
    >> Share

  40. MADONIS SM, Skelding KA, Roberts M
    Management of acute coronary syndromes: special considerations in women.
    Heart. 2017;103:1638-1646.
    >> Share

    September 2017
  41. ZHAO M, Vaartjes I, Graham I, Grobbee D, et al
    Sex differences in risk factor management of coronary heart disease across three regions.
    Heart. 2017 Sep 20. pii: heartjnl-2017-311429. doi: 10.1136/heartjnl-2017-311429
    >> Share

  42. ALBADRI A, Wei J, Mehta PK, Shah R, et al
    Sex differences in coronary heart disease risk factors: rename it ischaemic heart disease!
    Heart. 2017 Sep 20. pii: heartjnl-2017-311921. doi: 10.1136/heartjnl-2017-311921
    >> Share

  43. BUTTAR SN, Yan TD, Taggart DP, Tian DH, et al
    Long-term and short-term outcomes of using bilateral internal mammary artery grafting versus left internal mammary artery grafting: a meta-analysis.
    Heart. 2017;103:1419-1426.
    >> Share

  44. NAIROOZ R, Saad M, Elgendy IY, Mahmoud AN, et al
    Long-term outcomes of provisional stenting compared with a two-stent strategy for bifurcation lesions: a meta-analysis of randomised trials.
    Heart. 2017;103:1427-1434.
    >> Share

  45. WANG M, Vaez M, Dorner TE, Tiihonen J, et al
    Trajectories and characteristics of work disability before and after acute myocardial infarction.
    Heart. 2017 Sep 1. pii: heartjnl-2017-311950. doi: 10.1136/heartjnl-2017-311950.
    >> Share

    August 2017
  46. BERG J, Bjorck L, Nielsen S, Lappas G, et al
    Sex differences in survival after myocardial infarction in Sweden, 1987-2010.
    Heart. 2017 Aug 7. pii: heartjnl-2016-310281. doi: 10.1136/heartjnl-2016-310281.
    >> Share

  47. MAZNYCZKA AM, McCartney P, Berry C
    Reference invasive tests of microvascular injury in myocardial infarction.
    Heart. 2017 Aug 5. pii: heartjnl-2017-311695. doi: 10.1136/heartjnl-2017-311695.
    >> Share

  48. ALFREDSSON J, Neely B, Neely ML, Bhatt DL, et al
    Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes.
    Heart. 2017;103:1168-1176.
    >> Share

  49. WILSON S, Newby DE
    Predicting long-term bleeding risk after acute coronary syndrome: a step closer to optimising dual antiplatelet therapy duration?
    Heart. 2017;103:1143-1145.
    >> Share

    July 2017
  50. YILMAZ A
    Visualising inflammation after myocardial infarction with the use of iron oxide nanoparticles.
    Heart. 2017 Jul 20. pii: heartjnl-2017-311484. doi: 10.1136/heartjnl-2017-311484
    >> Share

  51. FABRIS E, Kilic S, Schellings DAAM, Ten Berg JM, et al
    Long-term mortality and prehospital tirofiban treatment in patients with ST elevation myocardial infarction.
    Heart. 2017 Jul 5. pii: heartjnl-2017-311181. doi: 10.1136/heartjnl-2017-311181.
    >> Share

  52. TIMMIS A, Roobottom CA
    National Institute for Health and Care Excellence updates the stable chest pain guideline with radical changes to the diagnostic paradigm.
    Heart. 2017;103:982-986.
    >> Share

  53. GONZALEZ LOPEZ-VALCARCEL B, Librero J, Garcia-Sempere A, Pena LM, et al
    Effect of cost sharing on adherence to evidence-based medications in patients with acute coronary syndrome.
    Heart. 2017;103:1082-1088.
    >> Share

  54. ZHOU RH, Yu H, Yin XR, Li Q, et al
    Effect of intralipid postconditioning on myocardial injury in patients undergoing valve replacement surgery: a randomised controlled trial.
    Heart. 2017;103:1122-1127.
    >> Share

  55. SHIMADA YJ, Tsugawa Y, Iso H, Brown DF, et al
    Association between bariatric surgery and rate of hospitalisations for stable angina pectoris in obese adults.
    Heart. 2017;103:1009-1014.
    >> Share

  56. HELSEN F, Vandenberk B, De Meester P, Van De Bruaene A, et al
    Appearance of QRS fragmentation late after Mustard/Senning repair is associated with adverse outcome.
    Heart. 2017;103:1036-1042.
    >> Share

  57. NAIROOZ R, Saad M, Sardar P, Aronow WS, et al
    Two-year outcomes of bioresorbable vascular scaffold versus drug-eluting stents in coronary artery disease: a meta-analysis.
    Heart. 2017;103:1096-1103.
    >> Share

  58. OHYA M, Kubo S, Kuwayama A, Miura K, et al
    Long-term (8-10 years) outcomes after biodegradable polymer-coated biolimus-eluting stent implantation.
    Heart. 2017;103:1002-1008.
    >> Share

  59. TIMMIS A, Roobottom C
    Re: The National Institute for Health and Care Excellence update for stable chest pain: poorly reasoned and risky for patients.
    Heart. 2017;103:1055.
    >> Share

  60. BRUGALETTA S, Sabate M
    A longer look at trial evidence of bioresorbable vascular scaffolds.
    Heart. 2017;103:1061-1062.
    >> Share

  61. OTTO CM, Luiz Ribeiro A
    Heartbeat: Anatomy versus physiology for diagnosis of coronary artery disease.
    Heart. 2017;103:969-971.
    >> Share

    June 2017
  62. DE WAARD GA, Fahrni G, de Wit D, Kitabata H, et al
    Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction.
    Heart. 2017 Jun 29. pii: heartjnl-2017-311431. doi: 10.1136/heartjnl-2017-311431
    >> Share

  63. NDREPEPA G
    Psychological distress and mortality in stable coronary heart disease: persistence of high distress means increased risk.
    Heart. 2017 Jun 26. pii: heartjnl-2017-311610. doi: 10.1136/heartjnl-2017-311610
    >> Share

  64. STIRRAT CG, Alam SR, MacGillivray TJ, Gray CD, et al
    Ferumoxytol-enhanced magnetic resonance imaging assessing inflammation after myocardial infarction.
    Heart. 2017 Jun 22. pii: heartjnl-2016-311018. doi: 10.1136/heartjnl-2016-311018
    >> Share

  65. FISHER SA, Doree C, Mathur A, Taggart DP, et al
    Cochrane Corner: stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
    Heart. 2017 Jun 12. pii: heartjnl-2017-311684. doi: 10.1136/heartjnl-2017-311684
    >> Share

  66. BIELINSKI SJ, Berardi C, Decker PA, Larson NB, et al
    Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease.
    Heart. 2017 Jun 1. pii: heartjnl-2016-310450. doi: 10.1136/heartjnl-2016-310450.
    >> Share

  67. MOSS AJ, Lim KH, Japp AG
    A 49-year-old with chest pain and collapse.
    Heart. 2017;103:968.
    >> Share

    May 2017
  68. RAJANI R, Modi B, Ntalas I, Curzen N, et al
    Non-invasive Fractional Flow Reserve using Computed Tomographic angiography: where are we now and where are we going?
    Heart. 2017 May 30. pii: heartjnl-2016-311029. doi: 10.1136/heartjnl-2016-311029
    >> Share

  69. LUIZ RIBEIRO A, Satoshi N, Catherine MO
    Heartbeat: Coronary heart disease, obesity, smoking and long-lasting psychological distress.
    Heart. 2017;103:644.
    >> Share

  70. LI X, Yu C, Guo Y, Bian Z, et al
    Tea consumption and risk of ischaemic heart disease.
    Heart. 2017;103:783-789.
    >> Share

  71. PERERA D, Uppal R, Hogan J
    A 72-year-old male with recurrent syncope.
    Heart. 2017;103:800.
    >> Share

    April 2017
  72. PRIOR DL, Stevens SR, Holly TA, Krejca M, et al
    Regional left ventricular function does not predict survival in ischaemic cardiomyopathy after cardiac surgery.
    Heart. 2017 Apr 26. pii: heartjnl-2016-310693. doi: 10.1136/heartjnl-2016-310693
    >> Share

  73. CADEMARTIRI F, Nistri S, Tarantini G, Maffei E, et al
    Management of coronary artery disease with cardiac CT beyond gatekeeping.
    Heart. 2017 Apr 26. pii: heartjnl-2016-310473. doi: 10.1136/heartjnl-2016-310473
    >> Share

  74. HOLTE E, Kleveland O, Ueland T, Kunszt G, et al
    Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction.
    Heart. 2017 Apr 21. pii: heartjnl-2016-310875. doi: 10.1136/heartjnl-2016-310875
    >> Share

  75. NADIR MA
    Inverse prognostic value of post-percutaneous coronary intervention fractional flow reserve in patients with non-ST segment elevation myocardial infarction.
    Heart. 2017;103:564.
    >> Share

  76. WILSON SJ, Newby DE, Dawson D, Irving J, et al
    Duration of dual antiplatelet therapy in acute coronary syndrome.
    Heart. 2017;103:573-580.
    >> Share

  77. AMBALE-VENKATESH B, Yoneyama K, Sharma RK, Ohyama Y, et al
    Left ventricular shape predicts different types of cardiovascular events in the general population.
    Heart. 2017;103:499-507.
    >> Share

  78. THOMPSON LE, Daugherty SL
    Gender disparities in cardiovascular disease prevention.
    Heart. 2017;103:479-480.
    >> Share

  79. DE SILVA K, Myat A, Cotton J, James S, et al
    Bleeding associated with the management of acute coronary syndromes.
    Heart. 2017;103:546-562.
    >> Share

    March 2017
  80. SEKIGUCHI H, Shimamoto K, Takano M, Kimura M, et al
    Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women.
    Heart. 2017 Mar 11. pii: heartjnl-2016-310272. doi: 10.1136/heartjnl-2016-310272
    >> Share

  81. ANDERSSON DP, Trolle Lagerros Y, Grotta A, Bellocco R, et al
    Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction.
    Heart. 2017 Mar 9. pii: heartjnl-2016-310746. doi: 10.1136/heartjnl-2016-310746.
    >> Share

  82. KUBLER P, Reczuch K
    Optimal stent treatment of cardiogenic shock complicating acute myocardial infarction: bare-metal or drug-eluting stent?
    Heart. 2017 Mar 3. pii: heartjnl-2016-311146. doi: 10.1136/heartjnl-2016-311146.
    >> Share

  83. WARD-CAVINESS CK, Xu T, Aspelund T, Thorand B, et al
    Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers.
    Heart. 2017 Mar 2. pii: heartjnl-2016-310789. doi: 10.1136/heartjnl-2016-310789.
    >> Share

  84. CAVALCANTE R, Sotomi Y, Zeng Y, Lee CW, et al
    Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery.
    Heart. 2017;103:428-433.
    >> Share

  85. MOSS AJ, Dweck MR, Flapan AD
    A 33-year-old man with atypical chest pain.
    Heart. 2017;103:474.
    >> Share

    February 2017
  86. WILLIAMS MC, Hunter A, Shah A, Assi V, et al
    Symptoms and quality of life in patients with suspected angina undergoing CT coronary angiography: a randomised controlled trial.
    Heart. 2017 Feb 28. pii: heartjnl-2016-310129. doi: 10.1136/heartjnl-2016-310129
    >> Share

  87. LEDWOCH J, Fuernau G, Desch S, Eitel I, et al
    Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock.
    Heart. 2017 Feb 7. pii: heartjnl-2016-310403. doi: 10.1136/heartjnl-2016-310403.
    >> Share

    January 2017
  88. DANZI GB, Piccolo R, Chevalier B, Urban P, et al
    Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patients.
    Heart. 2017;103:111-116.
    >> Share

  89. BUENO H, Pocock S, Danchin N, Annemans L, et al
    International patterns of dual antiplatelet therapy duration after acute coronary syndromes.
    Heart. 2017;103:132-138.
    >> Share

  90. VARCOE RW, Clayton TC, Gray HH, de Belder MA, et al
    Impact of call-to-balloon time on 30-day mortality in contemporary practice.
    Heart. 2017;103:117-124.
    >> Share

  91. CASSESE S, Xhepa E, Kastrati A
    Biodegradable-polymer drug-eluting stents: back to the future?
    Heart. 2017;103:91-92.
    >> Share

  92. GIAVARINI A, Kilic ID, Redondo Dieguez A, Longo G, et al
    Intracoronary Imaging.
    Heart. 2017 Jan 5. pii: heartjnl-2015-307888. doi: 10.1136/heartjnl-2015-307888.
    >> Share

  93. CHAPMAN AR, Adamson PD, Mills NL
    Assessment and classification of patients with myocardial injury and infarction in clinical practice.
    Heart. 2017;103:10-18.
    >> Share

    December 2016
  94. WILLIAMS RB
    Loneliness and social isolation and increased risk of coronary heart disease and stroke: clinical implications.
    Heart. 2016;102:2016.
    >> Share

  95. REINDL M, Reinstadler SJ, Feistritzer HJ, Mueller L, et al
    Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction.
    Heart. 2016 Dec 15. pii: heartjnl-2016-310520. doi: 10.1136/heartjnl-2016-310520
    >> Share

  96. DOMINGUEZ-RODRIGUEZ A, Abreu-Gonzalez P, Reiter RJ
    Melatonin for cardioprotection in ST elevation myocardial infarction: are we ready for the challenge?
    Heart. 2016 Dec 7. pii: heartjnl-2016-310689. doi: 10.1136/heartjnl-2016-310689.
    >> Share

  97. JENKINS WS, Vesey AT, Stirrat C, Connell M, et al
    Cardiac alphaVbeta3 integrin expression following acute myocardial infarction in humans.
    Heart. 2016 Dec 7. pii: heartjnl-2016-310115. doi: 10.1136/heartjnl-2016-310115.
    >> Share

    November 2016
  98. LLOYD A, Steele L, Fotheringham J, Iqbal J, et al
    Pronounced increase in risk of acute ST-segment elevation myocardial infarction in younger smokers.
    Heart. 2016 Nov 29. pii: heartjnl-2016-309595. doi: 10.1136/heartjnl-2016-309595
    >> Share

  99. EISEN A, Bhatt DL
    Optimal duration of dual antiplatelet therapy after acute coronary syndromes and coronary stenting.
    Heart. 2016 Nov 25. pii: heartjnl-2015-309022. doi: 10.1136/heartjnl-2015-309022
    >> Share

  100. VIRTANEN M, Elovainio M, Josefsson K, Batty GD, et al
    Coronary heart disease and risk factors as predictors of trajectories of psychological distress from midlife to old age.
    Heart. 2016 Nov 18. pii: heartjnl-2016-310207. doi: 10.1136/heartjnl-2016-310207
    >> Share

  101. MCMULLAN CJ, Rimm EB, Schernhammer ES, Forman JP, et al
    A nested case-control study of the association between melatonin secretion and incident myocardial infarction.
    Heart. 2016 Nov 2. pii: heartjnl-2016-310098. doi: 10.1136/heartjnl-2016-310098.
    >> Share

  102. CHAPMAN AR, Anand A, Shah AS, Adamson PD, et al
    Response: a novel troponin I rule-out value below the upper reference limit for acute myocardial infarction.
    Heart. 2016;102:1772.
    >> Share

    October 2016
  103. CEDIEL G, Gonzalez-Del-Hoyo M, Carrasquer A, Sanchez R, et al
    Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury.
    Heart. 2016 Oct 14. pii: heartjnl-2016-310243. doi: 10.1136/heartjnl-2016-310243
    >> Share

    September 2016
  104. GURUNATHAN S, Ahmed A, Pabla J, Karogiannis N, et al
    The clinical efficacy and long-term prognostic value of stress echocardiography in octogenarians.
    Heart. 2016 Sep 30. pii: heartjnl-2016-310026. doi: 10.1136/heartjnl-2016-310026
    >> Share

  105. MACINTYRE CR, Mahimbo A, Moa AM, Barnes M, et al
    Influenza vaccine as a coronary intervention for prevention of myocardial infarction.
    Heart. 2016 Sep 29. pii: heartjnl-2016-309983. doi: 10.1136/heartjnl-2016-309983
    >> Share

  106. NAIR A, Sajeev CG, Muneer K
    A case of recent myocardial infarction with cardiac failure.
    Heart. 2016 Sep 29. pii: heartjnl-2016-309715. doi: 10.1136/heartjnl-2016-309715
    >> Share

  107. JONES DA, Khambata RS, Andiapen M, Rathod KS, et al
    Intracoronary nitrite suppresses the inflammatory response following primary percutaneous coronary intervention.
    Heart. 2016 Sep 28. pii: heartjnl-2016-309748. doi: 10.1136/heartjnl-2016-309748
    >> Share

  108. OU SM, Chen HT, Kuo SC, Chen TJ, et al
    Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309687. doi: 10.1136/heartjnl-2016-309687
    >> Share

  109. COCKBURN J, Hildick-Smith D, Trivedi U, de Belder A, et al
    Coronary revascularisation in the elderly.
    Heart. 2016 Sep 14. pii: heartjnl-2015-308999. doi: 10.1136/heartjnl-2015-308999
    >> Share

    August 2016
  110. SHAH R, Mooney MA
    Complete versus culprit-only revascularisation for ST-segment elevation myocardial infarction.
    Heart. 2016;102:1335.
    >> Share

  111. NAVARESE E, Kowalewski M
    Complete versus culprit-only revascularisation for ST-segment elevation myocardial infarction.
    Heart. 2016;102:1335-6.
    >> Share

  112. BRADLEY SM, Otto CM
    Heartbeat: Rule-out of acute myocardial infarction - risky business.
    Heart. 2016;102:1249-50.
    >> Share

  113. MANGION K, Carrick D, Hennigan BW, Payne AR, et al
    Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention.
    Heart. 2016 Aug 8. pii: heartjnl-2015-308660. doi: 10.1136/heartjnl-2015-308660.
    >> Share

  114. LINDAHL B, Jernberg T, Badertscher P, Boeddinghaus J, et al
    An algorithm for rule-in and rule-out of acute myocardial infarction using a novel troponin I assay.
    Heart. 2016 Aug 2. pii: heartjnl-2016-309951. doi: 10.1136/heartjnl-2016-309951.
    >> Share

  115. OTTO CM
    Heartbeat: Prediction of coronary disease risk with cardiac troponin in the general population.
    Heart. 2016;102:1151-2.
    >> Share

    July 2016
  116. DI TANO G, Caretta G, De Maria R, Parolini M, et al
    Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
    Heart. 2016 Jul 27. pii: heartjnl-2016-309673. doi: 10.1136/heartjnl-2016-309673
    >> Share

  117. DEVI R, Singh SJ, Powell J, Fulton EA, et al
    Cochrane Corner: are there benefits of using web-based interventions in the secondary prevention of coronary heart disease?
    Heart. 2016 Jul 21. pii: heartjnl-2015-309138. doi: 10.1136/heartjnl-2015-309138
    >> Share

  118. PETRONI T, Zaman A, Georges JL, Hammoudi N, et al
    Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians.
    Heart. 2016 Jul 13. pii: heartjnl-2015-308905. doi: 10.1136/heartjnl-2015-308905
    >> Share

  119. MITTAL TK, Reichmuth L, Ariff B, Rao PP, et al
    Imaging diagnoses and outcome in patients presenting for primary angioplasty but no obstructive coronary artery disease.
    Heart. 2016 Jul 1. pii: heartjnl-2015-309039. doi: 10.1136/heartjnl-2015-309039.
    >> Share

    June 2016
  120. PARSONAGE WA, Mueller C, Greenslade JH, Wildi K, et al
    Validation of NICE diagnostic guidance for rule out of myocardial infarction using high-sensitivity troponin tests.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309270. doi: 10.1136/heartjnl-2016-309270
    >> Share

    May 2016
  121. PUDDU PE, Alexandre J
    Coronary heart disease and sexual activity.
    Heart. 2016 May 12. pii: heartjnl-2016-309505. doi: 10.1136/heartjnl-2016-309505
    >> Share

  122. NORDMANN A, Schwartz G, Vale N, Bucher HC, et al
    Cochrane corner: early statin therapy in acute coronary syndromes--what is the clinical benefit?
    Heart. 2016;102:653-4.
    >> Share

    April 2016
  123. HEMKENS LG, Ewald H, Gloy VL, Arpagaus A, et al
    Cardiovascular effects and safety of long-term colchicine treatment: Cochrane review and meta-analysis.
    Heart. 2016;102:590-6.
    >> Share

  124. SHAVELLE DM
    Almanac 2015: coronary artery disease.
    Heart. 2016;102:492-9.
    >> Share

    March 2016
  125. BRICENO N, Schuster A, Lumley M, Perera D, et al
    Ischaemic cardiomyopathy: pathophysiology, assessment and the role of revascularisation.
    Heart. 2016;102:397-406.
    >> Share

  126. BULLUCK H, Yellon DM, Hausenloy DJ
    Reducing myocardial infarct size: challenges and future opportunities.
    Heart. 2016;102:341-8.
    >> Share

  127. GAIBAZZI N
    Ultrasound contrast during stress echo: for obese patients, but not only.
    Heart. 2016;102:339-40.
    >> Share

  128. TARKIA M, Stark C, Haavisto M, Kentala R, et al
    Effect of levosimendan therapy on myocardial infarct size and left ventricular function after acute coronary occlusion.
    Heart. 2016;102:465-71.
    >> Share

  129. BUDOFF MJ
    Exercise capacity and biological age.
    Heart. 2016;102:415.
    >> Share

  130. BLAHA MJ, Hung RK, Dardari Z, Feldman DI, et al
    Age-dependent prognostic value of exercise capacity and derivation of fitness-associated biologic age.
    Heart. 2016;102:431-7.
    >> Share

  131. ARRI SS, Ryan M, Redwood SR, Marber MS, et al
    Mental stress-induced myocardial ischaemia.
    Heart. 2016;102:472-80.
    >> Share

  132. MISTRY A, McCann G, Skehan D
    Ischaemic chest pain in a 65-year-old man.
    Heart. 2016;102:471.
    >> Share

    February 2016
  133. VELDERS MA, Abtan J, Angiolillo DJ, Ardissino D, et al
    Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention.
    Heart. 2016 Feb 4. pii: heartjnl-2015-308963. doi: 10.1136/heartjnl-2015-308963.
    >> Share

    January 2016
  134. FORDYCE CB, Douglas PS
    Optimal non-invasive imaging test selection for the diagnosis of ischaemic heart disease.
    Heart. 2016 Jan 29. pii: heartjnl-2015-307764. doi: 10.1136/heartjnl-2015-307764
    >> Share

  135. AGUS AM, McKavanagh P, Lusk L, Verghis RM, et al
    The cost-effectiveness of cardiac computed tomography for patients with stable chest pain.
    Heart. 2016 Jan 14. pii: heartjnl-2015-308247. doi: 10.1136/heartjnl-2015-308247
    >> Share

  136. SHAH BN, Zacharias K, Pabla JS, Karogiannis N, et al
    The clinical impact of contemporary stress echocardiography in morbid obesity for the assessment of coronary artery disease.
    Heart. 2016 Jan 6. pii: heartjnl-2015-308796. doi: 10.1136/heartjnl-2015-308796.
    >> Share

  137. SINCLAIR H, Kunadian V
    Coronary revascularisation in older patients with non-ST elevation acute coronary syndromes.
    Heart. 2016 Jan 6. pii: heartjnl-2015-307859. doi: 10.1136/heartjnl-2015-307859.
    >> Share

  138. CULLEN L, Greenslade JH, Carlton EW, Than M, et al
    Sex-specific versus overall cut points for a high sensitivity troponin I assay in predicting 1-year outcomes in emergency patients presenting with chest pain.
    Heart. 2016;102:120-6.
    >> Share

  139. GIANNITSIS E
    Sex-specific troponin measures for diagnosis of acute coronary syndrome.
    Heart. 2016;102:91-2.
    >> Share

  140. TASEVSKA I, Enhorning S, Persson M, Nilsson PM, et al
    Copeptin predicts coronary artery disease cardiovascular and total mortality.
    Heart. 2016;102:127-32.
    >> Share

    December 2015
  141. DASTIDAR AG, Rodrigues JC, Baritussio A, Bucciarelli-Ducci C, et al
    MRI in the assessment of ischaemic heart disease.
    Heart. 2015 Dec 30. pii: heartjnl-2014-306963. doi: 10.1136/heartjnl-2014-306963
    >> Share

  142. SINTEK MA, Sparrow CT, Mikuls TR, Lindley KJ, et al
    Repeat revascularisation outcomes after percutaneous coronary intervention in patients with rheumatoid arthritis.
    Heart. 2015 Dec 30. pii: heartjnl-2015-308634. doi: 10.1136/heartjnl-2015-308634
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016